scholarly journals Treatment of Canine Cognitive Dysfunction With Novel Butyrylcholinesterase Inhibitor

2020 ◽  
Author(s):  
Maja Zakošek Pipan ◽  
Sonja Prpar Mihevc ◽  
Malan Štrbenc ◽  
Urban Košak ◽  
Ilija German Ilić ◽  
...  
Keyword(s):  
Cognitive Dysfunction ◽  
Butyrylcholinesterase Inhibitor

scholarly journals Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Maja Zakošek Pipan ◽  
Sonja Prpar Mihevc ◽  
Malan Štrbenc ◽  
Urban Košak ◽  
Ilija German Ilić ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Cognitive Dysfunction ◽  
Cognitive Abilities ◽  
Cognitive Status ◽  
Moderate Cognitive Impairment ◽  
Interesting Candidate ◽  
Butyrylcholinesterase Inhibitor

AbstractCanine cognitive dysfunction (CCD) is common in aged dogs and has many similarities with Alzheimer’s disease. Unfortunately, like Alzheimer’s disease, CCD cannot be cured. In the present study, we treated dogs with CCD with our newly developed and characterized butyrylcholinesterase inhibitor (BChEi). Seventeen dogs were randomized into two groups (treated with BChEi and untreated) and followed for 6 months at regular check-ups. The dogs’ cognitive status was determined by a Canine Dementia Scale (CADES) questionnaire and two cognitive tests. In dogs with moderate cognitive impairment, treatment caused significant improvement in the clinical rating of cognitive abilities and the performance-based tests of cognitive functioning when compared to the untreated group (p < 0.001). Dogs treated with BChEi showed markedly improved cognitive function with enhanced quality of life. No side effects were observed in the treated dogs with moderate cognitive impairment. According to the results of this preliminary study, there is an indication that novel BChEi may be a promising drug for the treatment of CCD in dogs and may be an interesting candidate for the treatment of Alzheimer's disease in humans. However, further clinical studies are needed to confirm this.

scholarly journals Treatment of Canine Cognitive Dysfunction With Novel Butyrylcholinesterase Inhibitor

2020 ◽  
Author(s):  
Maja Zakošek Pipan ◽  
Sonja Prpar Mihevc ◽  
Malan Štrbenc ◽  
Urban Košak ◽  
Ilija German Ilić ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Cognitive Dysfunction ◽  
Cognitive Abilities ◽  
Cognitive Status ◽  
Promising Candidate ◽  
Moderate Cognitive Impairment ◽  
Butyrylcholinesterase Inhibitor

Abstract Background: Canine cognitive dysfunction (CCD) is common in aged dogs and has many similarities with Alzheimer’s disease. Unfortunately, like Alzheimer’s disease, CCD cannot be cured. Methods: In the present study, we treated dogs with CCD with our newly developed and characterized butyrylcholinesterase inhibitor (BChEi). Seventeen dogs were randomized into two groups (treated with BChEi and untreated) and followed for 6 months at regular check-ups. The dogs’ cognitive status was determined by a CADES questionnaire and two cognitive tests. Results: In dogs with moderate cognitive impairment, treatment caused significant improvement in the clinical rating of cognitive abilities and the performance-based tests of cognitive functioning when compared to the untreated group (p < 0.001). Dogs treated with BChEi showed markedly improved cognitive function with enhanced quality of life. No side effects were observed in the treated dogs with moderate cognitive impairment. Conclusions: Novel BChE inhibitor is a promising candidate for treating CCD, and might be an interesting canidate drug for the treatment of Alzheimer disease in humans.

Postoperative Cognitive Dysfunction In Older Alcoholics

2007 ◽  
Author(s):  
Judith A. Hudetz ◽  
Diane Reddy ◽  
Kathleen Patterson ◽  
Anthony G. Hudetz ◽  
David C. Warltier
Keyword(s):  
Cognitive Dysfunction ◽  
Postoperative Cognitive Dysfunction

Meta-Analysis of Neurological Foci and Cognitive Dysfunction Correlates in Autism Spectrum Disorder

2012 ◽  
Author(s):  
Peter D. Marle ◽  
Alisa J. Estey ◽  
Frederick L. Coolidge
Keyword(s):  
Autism Spectrum Disorder ◽  
Cognitive Dysfunction ◽  
Meta Analysis ◽  
Autism Spectrum ◽  
Spectrum Disorder

Cerebral White Matter Atrophy and Cognitive Dysfunction Following TBI

2007 ◽  
Author(s):  
Tracy D. Vannorsdall ◽  
Vani Rao ◽  
David J. Schretlen
Keyword(s):  
White Matter ◽  
Cognitive Dysfunction ◽  
Cerebral White Matter

Clinically significant cognitive dysfunction in OEF/OIF/OND veterans: Prevalence and clinical associations.

2019 ◽  
Vol 33 (4) ◽  
pp. 534-546 ◽  
Author(s):  
Elizabeth Riley ◽  
Alex Mitko ◽  
Anna Stumps ◽  
Meghan Robinson ◽  
William Milberg ◽  
...  
Keyword(s):  
Cognitive Dysfunction ◽  
Clinical Associations ◽  
Clinically Significant

Hyperparathyroid-Related Cognitive Dysfunction Improves With Surgery

2007 ◽  
Vol 37 (6) ◽  
pp. 23
Author(s):  
BRUCE JANCIN
Keyword(s):  
Cognitive Dysfunction
Sign in / Sign up

Export Citation Format

Share Document